Naltrexone/bupropion (Contrave) for weight loss. Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial. The effects of dietary improvement on symptoms of depression and anxiety: A meta-analysis of randomized controlled trials. Physical Activity Guidelines for Americans, 2nd ed.įirth J, Marx W, Dash S, et al. The role of exercise and physical activity in weight loss and maintenance. Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. Weight gain and associated factors in patients using new antidepressant drugs. Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R. SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles: results from a 4-year Australian follow-up study. Is increased antidepressant exposure a contributory factor to the obesity pandemic?. Lee SH, Paz-Filho G, Mastronardi C, Licinio J, Wong ML. Long-term antidepressant use: Patient perspectives of benefits and adverse effects. Bupropion: A systematic review and meta-analysis of effectiveness as an antidepressant. Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK. Addressing the side effects of contemporary antidepressant drugs: A comprehensive review. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: Population based cohort study. Antidepressants and body weight: a comprehensive review and meta-analysis. Antidepressant medications and weight change: A narrative review.
0 Comments
Leave a Reply. |